Telix Pharmaceuticals Limited American Depositary Shares share price logo

Telix Pharmaceuticals Limited American Depositary Shares

NASDAQ: TLX

Mid Cap

$11.68

+0.35

(+3.09%)

as on

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

as on August 25, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $11.49
    $11.76
    downward going graph

    1.63%

    Downside

    0.68%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.28
    $12.60
    downward going graph

    46.23%

    Downside

    7.88%

    Upside

    downward going graph

Telix Pharmaceuticals Limited American Depositary Shares share price movements today

Previous Close
$11.33
Open
$11.49
Volume
403.9K
Market Cap
$4.0B
Day's Low - High
$11.49 - $11.76
52 Week Low - High
$6.28 - $12.60

Telix Pharmaceuticals Limited American Depositary Shares Historical Returns

1 Month Return
+ 13 %
3 Month Return
+ 11.93 %
1 Year Return
+ 2.43 %
3 Year Return
0 %
5 Year Return
0 %

Telix Pharmaceuticals Limited American Depositary Shares Stock Fundamentals & Key Indicators

Check Telix Pharmaceuticals Limited American Depositary Shares market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.0B

EPS (TTM)

0.072

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-1.86%

Telix Pharmaceuticals Limited American Depositary Shares vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Telix Pharmaceuticals Limited American Depositary Shares with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Telix Pharmaceuticals Limited American Depositary Shares image
Telix Pharmaceuticals Limited American Depositary Shares
NA$4.0BNANA-0.89%NA
Revolution Medicines image
Revolution Medicines
BUY$43.7B669.3%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$128.2B154.86%29.8286.04%NA
Moderna image
Moderna
BUY$25.3B-84.24%-7.98-12.57%NA
Regeneron image
Regeneron
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Telix Pharmaceuticals Limited American Depositary Shares Stock including INR - Dollar returns

The Telix Pharmaceuticals Limited American Depositary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Telix Pharmaceuticals Limited American Depositary Shares investment value today

Current value as on today

₹1,10,602

Returns

₹10,602

(+10.6%)

Returns from Telix Pharmaceuticals Limited American Depositary Shares Stock

₹1,213 (+1.21%)

Dollar Impact

₹9,388 (+9.39%)

Indian Investors' Interest in Telix Pharmaceuticals Limited American Depositary Shares Stock

Search interest for Telix Pharmaceuticals Limited American Depositary Shares Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:11% versus previous 30 day period

Telix Pharmaceuticals Limited American Depositary Shares Quarterly Profit & Loss

All numbers in Millions USD

Jun 2021
Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Total Revenue
2
4
24
136
220
281
188
594
593
620
Gross Profit
-11
-18
-15
44
90
223
123
385
288
327
Operating Income
-31
-49
-63
-9
31
-15
13
68
15
9
EBITDA
-33
-59
-67
-24
-8
22
40
82
8
28
Interest Expense
0
0
0
0
0
0
4
16
3
11
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-37
-61
-70
-27
-12
15
9
46
-7
0
Income Tax Expense
-4
-13
0
5
2
-4
-2
8
3
6
Net Income
-32
-47
-70
-33
-14
19
11
38
-3
-7
Net Profit Margin
-1117.32%
-1024.24%
-294.80%
-24.39%
-6.48%
6.93%
6.18%
6.43%
-0.59%
-1.17%

Telix Pharmaceuticals Limited American Depositary Shares Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
29
31
0
3
5
7
160
336
495
1,205
Gross Profit
8
0
0
-11
3
5
94
210
322
640
Operating Income
0
-6
-29
-36
-44
-81
-91
15
82
26
EBITDA
0
-6
-27
-24
-44
-70
-92
22
98
79
Interest Expense
0
0
0
2
1
0
0
8
21
55
Depreciation
-
-
-
-
4
5
5
6
-
-
Income Before Tax
0
-6
-15
-31
-60
-99
-98
3
56
-7
Income Tax Expense
0
0
-1
-3
-15
-18
5
-2
6
2
Net Income
0
-6
-13
-27
-44
-80
-104
3
31
-10
Net Profit Margin
-0.15%
-20.07%
-7087.06%
-799.63%
-861.06%
-1059.90%
-65.01%
1.04%
6.37%
-0.89%

Telix Pharmaceuticals Limited American Depositary Shares Quarterly Cash Flow

All numbers in Millions USD

Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Net Income
-47
-70
-33
-14
19
29
20
-3
-7
Operating Cash Flow
-30
-60
-3
13
10
34
3
26
-52
Investing Cash Flow
-1
-11
-5
-2
-22
-45
-89
-396
-41
Financing Cash Flow
2
171
3
4
5
2
636
-4
-1
Change in Cash
-27
100
-6
15
-8
-7
591
-356
-97

Telix Pharmaceuticals Limited American Depositary Shares Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-13
-27
-44
-80
-104
5
49
-10
Operating Cash Flow
-6
-20
-23
1
-59
-63
23
43
-25
Investing Cash Flow
0
-2
0
-1
-2
-16
-25
-135
-428
Financing Cash Flow
54
0
42
34
2
174
10
638
-5
Change in Cash
54
-22
18
33
-55
94
6
587
-446

Global Institutional Holdings in Telix Pharmaceuticals Limited American Depositary Shares

Funds
Holdings
Vident Advisory, LLC
0%
NLB Skladi, upravljanje premozenja, d.o.o.
0.02%
JustInvest LLC
0.01%
JPMorgan Chase & Co
0.02%
XTX Topco Ltd
0.01%
See all

Telix Pharmaceuticals Limited American Depositary Shares News & Key Events

  • img

    Today's Timeline - 13 April

    Mon, 04:18 PM

    -

    Telix partners with Regeneron for up to $4.3 billion in radiopharmaceutical therapies, receiving $40 million upfront.

    Mon, 06:08 PM

    -

    Telix's FDA accepted NDA for TLX101-Px1; shares rose 5.79% in premarket trading.

Insights on Telix Pharmaceuticals Limited American Depositary Shares

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, TLX stock has moved up by 72.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 493.2% return, outperforming this stock by 497.5%

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250, an rADC for treating advanced metastatic kidney cancer; TLX101, a systemic therapy for the treatment of glioblastoma; TLX66, a product candidate for bone marrow conditioning for hematopoietic stem cell transplant conditioning; and Illuccix and Gozellix for the treatment of prostate cancer. The company is also developing TLX592, a prostate cancer therapy candidate for targeted alpha therapy based on its proprietary RADmAb-engineered antibody technology; TLX252 for the treatment of patients with advanced metastatic kidney cancer; TLX400, a bladder fibroblast activation protein for treating various tumors; TLX102, a large amino acid transporter-targeting small molecule-based alpha therapy candidate for the treatment of glioblastoma and multiple myeloma; TLX300 for treating soft tissue sarcoma; and TLX090, a bone-seeking agent for bone metastases and pain palliation. In addition, it is developing BiPASS, which is in Phase 3 clinical trial for prostate cancer diagnosis; AlFluor, a novel PET radiochemistry solution; TLX250-Px, a PET diagnostic imaging agent; and TLX101-Px, a radiolabeled amino acid PET agent. It operates in Australia, Belgium, Canada, the United Kingdom, the United States, and internationally. The company has strategic collaboration with University Hospital Essen. The company was founded in 2015 and is headquartered in North Melbourne, Australia.
OrganisationTelix Pharmaceuticals Limited American Depositary Shares
Headquarters55 Flemington Road, North Melbourne, VIC, Australia, 3051
IndustryBiotechnology
CEODr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., Ph.D
E-voting on sharesClick here to vote

Key Management of Telix Pharmaceuticals Limited American Depositary Shares

Name

Title

Thomas Fromm

Vice President of Sales

Mr. Darren Smith B.Bus., FCPA, M.B.A.

Group Chief Financial Officer

Mr. Craig Ulrick

Chief Information Officer

Ms. Kyahn Williamson B.A.

Senior Vice President of Corporate Communications & Investor Relations

Dr. Paul Schaffer

SVP of Research & Development

Mr. Christian Krautkramer J.D.

Group General Counsel

Ms. Meredith Crowe BDES

Senior Vice President of Global People & Culture

Dr. Christian P. Behrenbruch BEng(Hons), DPhil(Oxon), GAICD, J.D., M.B.A., Ph.D

Co-Founder, MD, Group CEO & Executive Director

Mr. Darren Patti Pharm.D.

Group Chief Operating Officer

Dr. David N. Cade M.B.A., M.D., MBBS

Group Chief Medical Officer

FAQs

What is Telix Pharmaceuticals Limited American Depositary Shares share price today?

Telix Pharmaceuticals Limited American Depositary Shares share price today is $11.68 as on at the close of the market. Telix Pharmaceuticals Limited American Depositary Shares share today touched a day high of $11.76 and a low of $11.49.

What is the 52 week high and 52 week low for Telix Pharmaceuticals Limited American Depositary Shares share?

Telix Pharmaceuticals Limited American Depositary Shares share touched a 52 week high of $12.60 on and a 52 week low of $6.28 on . Telix Pharmaceuticals Limited American Depositary Shares stock price today i.e. is closed at $11.68,which is 7.30% down from its 52 week high and 85.99% up from its 52 week low.

What is Telix Pharmaceuticals Limited American Depositary Shares's market capitalisation today?

Telix Pharmaceuticals Limited American Depositary Shares market capitalisation is $0.00T as on .

How to invest in Telix Pharmaceuticals Limited American Depositary Shares Stock (TLX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Telix Pharmaceuticals Limited American Depositary Shares on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Telix Pharmaceuticals Limited American Depositary Shares Shares that will get you 0.1284 shares as per Telix Pharmaceuticals Limited American Depositary Shares share price of $11.68 per share as on August 25, 2026 at 8:46 am IST.

What is the minimum amount required to buy Telix Pharmaceuticals Limited American Depositary Shares Stock (TLX) from India?

Indian investors can start investing in Telix Pharmaceuticals Limited American Depositary Shares (TLX) shares with as little as ₹95.735 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.35 in Telix Pharmaceuticals Limited American Depositary Shares stock (as per the Rupee-Dollar exchange rate as on ). Based on Telix Pharmaceuticals Limited American Depositary Shares share’s latest price of $11.68 as on August 25, 2026 at 8:46 am IST, you will get 0.8562 shares of Telix Pharmaceuticals Limited American Depositary Shares. Learn more about fractional shares .